Nezam Afdhal, MD
Enriched profileChief, Division of Gastroenterology and Professor of Medicine, Harvard Medical School · Beth Israel Deaconess Medical Center
Nezam Afdhal is Chief, Division of Gastroenterology and Professor of Medicine, Harvard Medical School at Beth Israel Deaconess Medical Center. OpenAlex indexes 544 publications with 37,271 citations (h-index 94); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 8 Oct 2026
Overview
Updated 12 Oct 2026
Nezam Afdhal, MD, is Chief, Division of Gastroenterology and Professor of Medicine, Harvard Medical School at Beth Israel Deaconess Medical Center. The public record shows 544 publications with 37,271 citations (h-index 94), centered on Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Liver Disease and Transplantation. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 9 companies, 6 NIH-funded awards (1993–2007).
- Most recent indexed publication: 2024 · WFUMB ultrasound open
- Top research focus: Hepatitis C virus research
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 282.
Clinical & industry
trials, payments and federal fundingContact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 12 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment
Sponsor: National Center for Complementary and Integrative Health (NCCIH)
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Sponsor: Romark Laboratories L.C.
Industry payments
Updated 12 Oct 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Intercept Pharmaceuticals, Inc.Program year20255 payments$45,700openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20252 payments$14,640openpaymentsdata.cms.gov ↗
- Intercept Pharmaceuticals, Inc.Program year20242 payments$72,566openpaymentsdata.cms.gov ↗
NIH funding
Updated 12 Oct 2026
6 NIH research awards on record, funded 1993–2007 per NIH RePORTER. The latest:
- Clinical Center for Phase I/II trials of Silymarin in Chronic Liver Disease
Beth Israel Deaconess Medical Center
FY2007$340,177U01AT003571 - PHASE I STUDY OF SILYMARIN IN CHRONIC HEPATITIS C OR FATTY LIVER DISEASE
Beth Israel Deaconess Medical Center
FY2007$12,916M01RR001032
Congress activity
Updated 12 Oct 2026
2 congress contributions (2017–2019) across ADA, ASCO per OpenAlex. The most recent:
- 1876-P: Impact of Diabetes on Liver Disease Progression in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis (NASH)
ADA Scientific Sessions
ADA2019Co-authorPoster - Preclinical studies of SB 11285, a novel STING agonist for immuno-oncology.
ASCO Annual Meeting
ASCO2017Co-authorOnline-only
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 12 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Methods and Validation of Velacur Determined Fat Fraction in patients with MASLD.
WFUMB ultrasound open
Article2024 - Serum protein risk stratification score for diagnostic evaluation of metabolic dysfunction-associated steatohepatitis.
Hepatology communications
Article2024 - The Use of Noninvasive Velacur® for Discriminating between Volunteers and Patients with Chronic Liver Disease: A Feasibility Study.
International journal of hepatology
Article2024
Most-cited works
by citation count (OpenAlex)- 01Liver cirrhosisArticle1,927 citations2008
- 02
- 03Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionArticle1,718 citations2014
- 04Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 InfectionArticle1,312 citations2014
- 05Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 InfectionArticle862 citations2015
Network
Updated 12 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 12 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/nezam-afdhal-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 12 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
- Honorary Doctor of Science
Royal College of Surgeons in Ireland
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →academicmedicaleducation.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Matcheri Keshavan, MD
Beth Israel Deaconess Medical Center
Connie Tsao, MD
Beth Israel Deaconess Medical Center
Donald Cutlip, MD
Beth Israel Deaconess Medical Center
Robert Yeh, MD
Beth Israel Deaconess Medical Center
Charles Rice, MD
The Rockefeller University
Kris Kowdley, MD
Washington State University
Eamonn Quigley, MD
Houston Methodist Hospital and Academic Institute
Patrick Kamath, MD
Mayo Clinic